Rashtriya Newsflash

How Creative Biolabs Advances ADCC Research Through Standardized Cell Systems

How Creative Biolabs Advances ADCC Research Through Standardized Cell Systems

Creative Biolabs has developed and integrated new technologies that analyze ADCC mechanisms and perform functional evaluations for antibody engineering. New York, USA – October 21, 2025 – In terms of

Read Full Article

Creative Biolabs Enhances Antibody Portfolio: Hi-Affi™ Recombinant Antibodies & Panels

Creative Biolabs releases an expanded antibody portfolio covering Hi-Affi™ recombinant antibodies, ready-to-use antibody panels, and innovative antibody formats to empower global R&D efficiency. New York, USA – October 21, 2025

Read Full Article

From Huawei and BYD to Feihe: Symbiosis as Chinese Wisdom in Forging Global Competitiveness

SANTIAGO, Chile – Oct 21, 2025 – At the International Dairy Federation (IDF) World Dairy Summit 2025, Feihe, China’s leading infant formula producer, took the stage as the only Chinese

Read Full Article

KingKonree Supplies 470 Custom Wudu Basins to Imam Al-Bukhari Memorial Complex in Uzbekistan

KingKonree International China Surface Industrial Co., Ltd. has supplied 470 custom-made wudu wash basins to the Imam Al-Bukhari Memorial Complex in Uzbekistan, marking a significant installation at one of the

Read Full Article

Affordable SEO by Marketing 1on1: Making Expert Optimization Accessible for Every Business Budget

Marketing 1on1 offers affordable SEO services that can make expert optimization easily accessible for all kinds of businesses, irrespective of

Read Full Article

Non-Alcoholic Steatohepatitis Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Viking Therapeutics, Seal Rock Therapeutics, AstraZeneca, Boehringer Ingelheim

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Non-Alcoholic Steatohepatitis pipeline constitutes 100+ key companies continuously working towards

Read Full Article

Graft-Versus Host Disease Market Expected to Gain Momentum Through 2034, According to DelveInsight | CSL Behring, Equillium, Biocon, MaaT Pharma, Regimmune, Jazz Pharma, Pharmacyclics LLC., Novartis

The Key Graft-Versus-Host Disease Companies in the market include – CSL Behring, Equillium, Biocon, MaaT Pharma, Regimmune, Jazz Pharmaceuticals, Pharmacyclics

Read Full Article

Frontotemporal Dementia Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Alector, Oncolys BioPharma, Denali Therapeutics Inc, Passage Bio

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Frontotemporal Dementia pipeline constitutes 15+ key companies continuously working towards

Read Full Article

Upcoming Book The 3 Pillars of False Doctrine Challenges the Core Teachings of Modern Christianity

Authors Sean Walsh and Don Roth Urge “Christians” to Rethink What They’ve Been Taught About the Bible. A thought-provoking upcoming

Read Full Article

Edward H Muoz Releases Inspiring Memoir Challenges Triumphs and Heroes Memoirs of My Celanese Odyssey

Edward H. Muñoz, a first-generation Mexican-American and celebrated leader in the global chemical industry, announces the release of his debut

Read Full Article